Cargando…

Contact allergens in moisturizers in preventative emollient therapy – A systematic review

BACKGROUND: Results of preventative emollient therapy on atopic dermatitis and food allergy trials are inconsistent. In addition to the ingredients considered beneficial, the moisturizers may contain potentially harmful haptens. This study aimed to assess the prevalence of haptens in moisturizers us...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryczaj, Klaudia, Dumycz, Karolina, Spiewak, Radoslaw, Feleszko, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168229/
https://www.ncbi.nlm.nih.gov/pubmed/35677673
http://dx.doi.org/10.1002/clt2.12150
_version_ 1784720957167894528
author Ryczaj, Klaudia
Dumycz, Karolina
Spiewak, Radoslaw
Feleszko, Wojciech
author_facet Ryczaj, Klaudia
Dumycz, Karolina
Spiewak, Radoslaw
Feleszko, Wojciech
author_sort Ryczaj, Klaudia
collection PubMed
description BACKGROUND: Results of preventative emollient therapy on atopic dermatitis and food allergy trials are inconsistent. In addition to the ingredients considered beneficial, the moisturizers may contain potentially harmful haptens. This study aimed to assess the prevalence of haptens in moisturizers used in studies to prevent atopic dermatitis or food allergy and assess their correlations to the trial results. METHODS: A systematic search of studies investigating the role of emollient usage in preventing atopic dermatitis or food allergy in infants was performed from inception to December 2020. Haptens were identified based on the nine common patch test series (European, American, and Australian). RESULTS: 12 clinical trial studies were included in the review. In total, 16 different emollients were applied as an intervention. The vast majority (75%) of preparations contained at least one hapten from which several substances pose high allergic or irritant potential. Quantitative data synthesis of the findings regarding food allergy and atopic dermatitis prevention was not possible due to the significant heterogeneity of preparations used. CONCLUSIONS: Careful selection of emollient should consider the absence of potentially harmful ingredients, particularly when used in youngest children. Chronic skin exposure to haptens promotes the development of allergic contact dermatitis and moreover, via deterioration of the skin barrier and subclinical inflammation, may facilitate epicutaneous sensitization and promote atopic dermatitis; however further research is needed to validate our suppositions.
format Online
Article
Text
id pubmed-9168229
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-91682292022-06-07 Contact allergens in moisturizers in preventative emollient therapy – A systematic review Ryczaj, Klaudia Dumycz, Karolina Spiewak, Radoslaw Feleszko, Wojciech Clin Transl Allergy Letter BACKGROUND: Results of preventative emollient therapy on atopic dermatitis and food allergy trials are inconsistent. In addition to the ingredients considered beneficial, the moisturizers may contain potentially harmful haptens. This study aimed to assess the prevalence of haptens in moisturizers used in studies to prevent atopic dermatitis or food allergy and assess their correlations to the trial results. METHODS: A systematic search of studies investigating the role of emollient usage in preventing atopic dermatitis or food allergy in infants was performed from inception to December 2020. Haptens were identified based on the nine common patch test series (European, American, and Australian). RESULTS: 12 clinical trial studies were included in the review. In total, 16 different emollients were applied as an intervention. The vast majority (75%) of preparations contained at least one hapten from which several substances pose high allergic or irritant potential. Quantitative data synthesis of the findings regarding food allergy and atopic dermatitis prevention was not possible due to the significant heterogeneity of preparations used. CONCLUSIONS: Careful selection of emollient should consider the absence of potentially harmful ingredients, particularly when used in youngest children. Chronic skin exposure to haptens promotes the development of allergic contact dermatitis and moreover, via deterioration of the skin barrier and subclinical inflammation, may facilitate epicutaneous sensitization and promote atopic dermatitis; however further research is needed to validate our suppositions. John Wiley and Sons Inc. 2022-06-05 /pmc/articles/PMC9168229/ /pubmed/35677673 http://dx.doi.org/10.1002/clt2.12150 Text en © 2022 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter
Ryczaj, Klaudia
Dumycz, Karolina
Spiewak, Radoslaw
Feleszko, Wojciech
Contact allergens in moisturizers in preventative emollient therapy – A systematic review
title Contact allergens in moisturizers in preventative emollient therapy – A systematic review
title_full Contact allergens in moisturizers in preventative emollient therapy – A systematic review
title_fullStr Contact allergens in moisturizers in preventative emollient therapy – A systematic review
title_full_unstemmed Contact allergens in moisturizers in preventative emollient therapy – A systematic review
title_short Contact allergens in moisturizers in preventative emollient therapy – A systematic review
title_sort contact allergens in moisturizers in preventative emollient therapy – a systematic review
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168229/
https://www.ncbi.nlm.nih.gov/pubmed/35677673
http://dx.doi.org/10.1002/clt2.12150
work_keys_str_mv AT ryczajklaudia contactallergensinmoisturizersinpreventativeemollienttherapyasystematicreview
AT dumyczkarolina contactallergensinmoisturizersinpreventativeemollienttherapyasystematicreview
AT spiewakradoslaw contactallergensinmoisturizersinpreventativeemollienttherapyasystematicreview
AT feleszkowojciech contactallergensinmoisturizersinpreventativeemollienttherapyasystematicreview